Quantifying the immune response to a tissue-engineered porcine extracellular matrix

Area of Science:

• Biomaterials Science
• Immunology
• Cardiovascular Engineering

Background:

• Xenogenic heart valve replacements often fail due to chronic immune responses leading to structural deterioration.
• Developing improved scaffolds is crucial for enhancing the longevity and efficacy of prosthetic heart valves.

Purpose of the Study:

• To engineer a decellularized porcine extracellular matrix (ECM) scaffold.
• To recellularize the scaffold with homologous mesenchymal stem cells (MSCs).
• To evaluate the immunogenicity of the recellularized scaffold when exposed to human blood.

Main Methods:

• Porcine ECM was decellularized to remove cellular components.
• The decellularized ECM was recellularized with human MSCs.
• The recellularized matrix was exposed to whole blood, and inflammatory markers (IL-1β, TNF-α) were measured.

Main Results:

• Decellularization successfully removed cells, confirmed by DAPI staining.
• Mesenchymal stem cell presence was confirmed after recellularization.
• Recellularized matrix showed significantly reduced production of inflammatory cytokines IL-1β and TNF-α.

Conclusions:

• Recellularization of decellularized porcine ECM with MSCs effectively attenuates the xenogenic immune response.
• This engineered scaffold shows potential for addressing limitations in current prosthetic heart valve replacements.